Related Experiment Video
Updated: Aug 2, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
COVID-19 Outcomes in a US Cohort of Persons Living with HIV (PLWH)
Amanda Blair Spence1, Sameer Desale2, Jennifer Lee1
1Division of Infectious Diseases, Georgetown University Medical Center, Washington, DC 20007, USA.
Insights
Persons living with HIV (PLWH) experienced higher hospitalization rates and overall mortality from COVID-19 compared to HIV-seronegative individuals. However, mortality rates were similar once hospitalized, indicating a need for targeted interventions for PLWH.
Area of Science:
- Infectious Diseases
- Public Health
- Epidemiology
Background:
- Outcomes of coronavirus disease 2019 (COVID-19) in persons living with HIV (PLWH) have varied across studies.
- Understanding these outcomes is crucial for effective public health strategies and clinical management.
Purpose of the Study:
- To compare the clinical characteristics and outcomes of COVID-19 in PLWH versus a matched HIV-seronegative cohort.
- To identify factors associated with severe outcomes, including hospitalization and mortality, among PLWH with COVID-19.
Main Methods:
- A retrospective cohort study was conducted within a mid-Atlantic US healthcare system.
- Multivariate logistic regression analysis was used to determine factors associated with hospitalization and death/mechanical ventilation.
- PLWH with COVID-19 were compared to a matched cohort of HIV-seronegative individuals diagnosed with COVID-19.
Main Results:
- PLWH had significantly higher hospitalization rates (47% vs. 24%) and overall mortality (6% vs. 3%) compared to the HIV-seronegative group.
- Cardiovascular events, thrombotic events, acute kidney injury, and infections were similar between groups.
- Among hospitalized patients, mortality rates were comparable (14% for PLWH vs. 13% for HIV-seronegative).
- Older age, Medicaid insurance, and multimorbidity were associated with increased hospitalization and mortality risk in PLWH.
Conclusions:
- PLWH with COVID-19 face higher risks of hospitalization and overall mortality but not necessarily in-hospital mortality compared to HIV-seronegative individuals.
- Factors such as older age, multimorbidity, and insurance status contribute to worse outcomes in PLWH.
- Targeted interventions are essential to address modifiable inequities and improve COVID-19 outcomes for PLWH.
Abstract:
Reported coronavirus disease 2019 (COVID-19) outcomes in persons living with HIV (PLWH) vary across cohorts. We examined clinical characteristics and outcomes of PLWH with COVID-19 compared with a matched HIV-seronegative cohort in a mid-Atlantic US healthcare system. Multivariate logistic regression was used to explore factors associated with hospitalization and death/mechanical ventilation among PLWH. Among 281 PLWH with COVID-19, the mean age was 51.5 (SD 12.74) years, 63% were male, 86% were Black, and 87% had a HIV viral load <200 copies/mL. Overall, 47% of PLWH versus 24% (p < 0.001) of matched HIV-seronegative individuals were hospitalized. Rates of COVID-19 associated cardiovascular and thrombotic events, AKI, and infections were similar between PLWH and HIV-seronegative individuals. Overall mortality was 6% (n = 18/281) in PLWH versus 3% (n = 33/1124) HIV-seronegative, p < 0.0001. Among admitted patients, mortality was 14% (n = 18/132) for PLWH and 13% (n = 33/269) for HIV-seronegative, p = 0.75. Among PLWH, hospitalization associated with older age aOR 1.04 (95% CI 1.01, 1.06), Medicaid insurance aOR 2.61 (95% CI 1.39, 4.97) and multimorbidity aOR 2.98 (95% CI 1.72, 5.23). Death/mechanical ventilation associated with older age aOR 1.06 (95% CI 1.01, 1.11), Medicaid insurance aOR 3.6 (95% CI 1.36, 9.74), and multimorbidity aOR 4.4 (95% CI 1.55, 15.9) in adjusted analyses. PLWH were hospitalized more frequently than the HIV-seronegative group and had a higher overall mortality rate, but once hospitalized had similar mortality rates. Older age, multimorbidity and insurance status associated with more severe outcomes among PLWH suggesting the importance of targeted interventions to mitigate the effects of modifiable inequities.
More Related Videos
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
07:10Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Related Concept Videos
Retrovirus Life Cycles
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Sexually Transmitted Infections
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Bias in Epidemiological Studies
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...